Monte Rosa Therapeutics
GLUE
GLUE
160 hedge funds and large institutions have $1.01B invested in Monte Rosa Therapeutics in 2025 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% more funds holding
Funds holding: 129 → 160 (+31)
1.8% more ownership
Funds ownership: 97.22% → 99.02% (+1.8%)
25% less call options, than puts
Call options by funds: $4.75M | Put options by funds: $6.37M
Holders
160
Holding in Top 10
3
Calls
$4.75M
Puts
$6.37M
Top Buyers
| 1 | +$62.3M | |
| 2 | +$17M | |
| 3 | +$15.8M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$12.8M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$9.92M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$20.4M | |
| 3 | -$17.1M | |
| 4 |
AI
Alphabet Inc
Mountain View,
California
|
-$9.69M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$7.69M |
